Jun 30, 2026
18 MIN READ

What Is the Best Dose of Wegovy for Weight Loss?

Semaglutide dosing for weight loss follows a gradual increase pattern starting at 0.25 mg weekly, with most patients reaching therapeutic doses between 1.0 and 2.4 mg. The right dose depends on individual tolerance, metabolic factors, and treatment goals.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 30, 2026
18 MIN READ

what is the best dose of wegovy for weight loss? — PlexusDx GLP-1 education

Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, works by slowing stomach emptying and increasing feelings of fullness—a mechanism that typically requires dose optimization over 16 to 20 weeks to achieve maximum weight loss results. Finding your ideal dose isn't about jumping to the highest strength; instead, it involves a structured titration schedule that balances effectiveness with tolerability. PlexusDx offers compounded semaglutide injections starting at $149/month, allowing you to work with licensed healthcare providers to determine the dose that fits your body and goals.

How Semaglutide Dosing Works for Weight Loss

Semaglutide activates GLP-1 receptors in the brain and gut, reducing hunger signals and slowing the rate at which food leaves your stomach. This dual action creates sustained satiety, helping patients naturally consume fewer calories without severe restriction. Clinical trials show that weight loss accelerates as dose increases, but the relationship isn't linear—most meaningful results occur once patients reach their personal therapeutic threshold, which varies widely.

The standard titration schedule begins at 0.25 mg injected once weekly, increasing by 0.25 mg every four weeks until reaching your target dose. Most patients find their sweet spot between 1.0 mg and 2.4 mg weekly, though some individuals respond optimally at lower or higher amounts. Your prescribing provider adjusts this timeline based on your side effect profile, appetite suppression level, and weight loss progress.

Understanding the Four-Week Titration Schedule

The four-week intervals between dose increases allow your body to adapt to semaglutide's effects, reducing gastrointestinal side effects like nausea and constipation. During each week at a given dose, your GLP-1 receptors become increasingly sensitized, meaning early mild nausea often resolves by week three or four. Rushing through dose escalation increases the risk of unmanageable side effects and medication discontinuation—a primary reason why structured titration outperforms faster protocols.

At each dose level, you'll notice your relationship with food changing gradually. Week one might bring mild appetite suppression; by week three, you may feel genuinely full on smaller portions. This progressive adaptation helps your brain and body adjust naturally rather than experiencing a dramatic shift that some patients find uncomfortable. Your healthcare provider monitors your tolerance and weight loss velocity to confirm you're progressing as expected.

Factors That Influence Your Optimal Semaglutide Dose

Individual metabolic factors significantly impact the dose you'll need for weight loss results. Body weight, baseline insulin sensitivity, liver function, and even your genetic predisposition to GLP-1 receptor sensitivity all play roles in determining your therapeutic dose. The Precision Peptide Genetic Test offered by PlexusDx examines genetic variants like GLP1R rs6923761, which influences how effectively your receptors respond to semaglutide, helping your provider personalize your starting dose and expected titration pace.

Stomach sensitivity, pre-existing gastrointestinal conditions, and medications you take can shift the dose your body tolerates comfortably. Some patients achieve substantial weight loss at 0.5 mg weekly, while others require 2.0 mg or higher to reach their goals. Your prescribing provider considers your complete health history, previous weight loss attempts, and comorbidities—such as type 2 diabetes or hypertension—when establishing your personalized dose roadmap. Age, kidney function, and existing medications also influence how your body metabolizes semaglutide.

When to Stay at Your Current Dose Versus Increasing

The decision to increase your dose depends on several signs your provider evaluates monthly: consistent weight loss, manageable side effects, unchanged appetite suppression, and the absence of concerning blood sugar swings. If you're experiencing steady weight loss, reduced hunger cues, and stable gastrointestinal symptoms, your current dose may be your therapeutic sweet spot—and increasing it further might not yield better results while introducing unnecessary side effects. Many patients achieve their weight loss goals and maintain them indefinitely at doses lower than the maximum recommended strength.

If your weight loss plateau after staying stable for 4 to 6 weeks at a given dose, your provider may recommend increasing to the next level. Conversely, if you're managing significant nausea, vomiting, or constipation, you might benefit from staying at your current dose longer or pausing escalation until your body adapts. This individualized approach is why PlexusDx's compounded formulation and personalized provider support matter—your dose remains flexible based on your actual response, not a one-size-fits-all protocol.

Comparing Semaglutide Dosing to Tirzepatide for Weight Loss

Tirzepatide, a dual GLP-1 and GIP receptor agonist, uses a different dosing framework than semaglutide because it activates two metabolic pathways simultaneously. Tirzepatide trials show faster and sometimes greater weight loss than semaglutide at equivalent timepoints, which can influence your provider's recommendation if you're choosing between therapies. However, tirzepatide's more potent appetite suppression also increases nausea risk early in titration, making patient tolerance a key consideration. PlexusDx offers both compounded semaglutide injections (starting at $149/month) and compounded tirzepatide injections (starting at $249/month), allowing your provider to select the best fit based on your medical history and response profile.

Some patients respond better to one pathway activation than the other, which is where genetic insights become valuable. Your Precision Peptide Genetic Test results reveal your GIPR rs1800437 status and other GIP-pathway variants that predict how strongly tirzepatide will work for you compared to semaglutide alone. Your provider uses these personalized predictors alongside clinical judgment to recommend either single-agent semaglutide, single-agent tirzepatide, or PlexusDx's innovative GLP-Squared dual-compound injection (starting at $249/month) for synergistic metabolic activation.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected subcutaneously once per week. This low initial dose allows your body to tolerate the medication while you build receptor sensitivity. After four weeks, your provider increases the dose by 0.25 mg weekly until reaching your therapeutic dose, typically between 1.0 and 2.4 mg.

How long does it take to reach the maximum semaglutide dose?

Full titration from 0.25 mg to 2.4 mg typically takes 16 to 20 weeks, with four-week intervals between increases. However, many patients achieve their weight loss goals at lower doses—around 1.0 to 1.5 mg—and never require the maximum strength. Your provider adjusts your timeline based on your tolerance and results, which is why PlexusDx's flexible, personalized approach works better than fixed schedules.

Can I skip doses or increase faster to lose weight quicker?

Accelerating titration dramatically increases nausea, vomiting, and gastrointestinal distress, often causing patients to discontinue therapy entirely. Skipping doses disrupts steady-state blood levels and can trigger rebound appetite. The four-week titration schedule is evidence-based and optimizes both safety and long-term adherence—your weight loss results depend on staying on the medication consistently, not on rushing the dose escalation.

What happens if my side effects worsen at a higher dose?

If you develop intolerable nausea or gastrointestinal symptoms after a dose increase, your provider can pause at your current dose longer, reduce back to your previous dose, or slow future escalation. PlexusDx providers monitor your response monthly and adjust your plan accordingly. Many patients find their optimal dose causes mild early symptoms that resolve by week three, but if symptoms persist, your dose is adjusted downward—your dose may increase, but your cost won't at PlexusDx.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes genetic variants including GLP1R rs6923761, which predicts how sensitively your receptors respond to semaglutide. This insight helps your provider estimate whether you'll likely need a lower dose for results or a higher dose for adequate response, personalizing your entire titration roadmap. The test also reveals FTO rs9939609 and MC4R rs17782313 variants that influence your weight regulation biology, guiding your provider's therapy selection between semaglutide, tirzepatide, or dual-compound options.

Is compounded semaglutide as effective as brand-name Wegovy?

Compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient at the same concentrations as Wegovy, delivered via the same injection mechanism. The primary difference is cost—PlexusDx compounded semaglutide starts at $149/month with no insurance requirement, HSA/FSA eligibility, and no membership fees. Effectiveness depends on consistent dosing, adherence, and lifestyle factors, not whether your semaglutide is compounded or branded.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves